Technical report series: cytokines

Biological products, rDNA

Title: Biological products prepared by recombinant DNA technology; Adopted 1990, TRS No 814, Annex 3

Interferons, human

Title: Requirements for Human Interferons prepared from Lymphoblastoid Cells; Adopted 1988, TRS No 786, Annex 3

Interferons, human

Title: Requirements for Human interferons made by recombinant DNA techniques; Adopted 1987, TRS No 771, Annex 7


WHO Drafting Group Meeting on the Revision of TRS 962, Annex 1

(Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines) 29-30 April 2014, WHO/HQ, Geneva

Implementation Workshop on Evaluation of Biotherapeutic Products and Evaluation of Similar Biotherapeutic products with emphasis on Monoclonal Antibody Products

13-16 May 2014, Seoul, The Republic of Korea


Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971